MARCHIO', Serena
 Distribuzione geografica
Continente #
NA - Nord America 3.190
EU - Europa 1.539
AS - Asia 857
OC - Oceania 23
SA - Sud America 9
AF - Africa 7
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.626
Nazione #
US - Stati Uniti d'America 3.110
CN - Cina 528
IT - Italia 408
IE - Irlanda 226
GB - Regno Unito 157
SE - Svezia 126
DE - Germania 125
VN - Vietnam 117
FR - Francia 113
FI - Finlandia 107
PL - Polonia 90
UA - Ucraina 88
CA - Canada 78
KR - Corea 54
JP - Giappone 47
SG - Singapore 33
AT - Austria 28
AU - Australia 23
BE - Belgio 23
IN - India 16
TW - Taiwan 15
NL - Olanda 14
HK - Hong Kong 12
RU - Federazione Russa 11
IR - Iran 9
TR - Turchia 9
BR - Brasile 6
ES - Italia 5
NO - Norvegia 5
UZ - Uzbekistan 4
DK - Danimarca 3
RO - Romania 3
TH - Thailandia 3
CH - Svizzera 2
CL - Cile 2
IL - Israele 2
JO - Giordania 2
MO - Macao, regione amministrativa speciale della Cina 2
MX - Messico 2
NG - Nigeria 2
CZ - Repubblica Ceca 1
EG - Egitto 1
ET - Etiopia 1
EU - Europa 1
GR - Grecia 1
LU - Lussemburgo 1
MA - Marocco 1
MY - Malesia 1
PE - Perù 1
PH - Filippine 1
PK - Pakistan 1
PT - Portogallo 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TN - Tunisia 1
Totale 5.626
Città #
Chandler 357
Fairfield 326
Beijing 267
Dublin 224
Woodbridge 214
Ashburn 198
Houston 167
Ann Arbor 144
Seattle 121
Wilmington 120
Torino 115
Cambridge 112
Pisa 106
Jacksonville 93
Villeurbanne 90
Warsaw 90
Dong Ket 81
Dearborn 79
Nyköping 77
Princeton 73
Mcallen 71
Medford 71
Montréal 59
Munich 57
Shanghai 40
Fremont 28
Vienna 28
Guangzhou 26
Boston 23
Brussels 22
Turin 22
San Diego 21
Nanjing 18
Redwood City 16
Helsinki 14
Milan 14
Hangzhou 13
Phoenix 13
Taipei 11
Toronto 11
Kunming 10
Singapore 10
Tokyo 9
Wuhan 9
Boardman 8
Fukuoka 8
Hefei 8
Upper Marlboro 8
Los Angeles 7
New York 7
Scuola 7
Washington 7
Xian 7
Cedar Crest 6
Central District 6
Moncalieri 6
Norwalk 6
Pittsburgh 6
Pune 6
Changsha 5
Chengdu 5
Düsseldorf 5
Genova 5
Jinan 5
San Jose 5
Silver Spring 5
Canberra 4
Chongqing 4
Crescentino 4
Cuneo 4
Falls Church 4
Harbin 4
Lanzhou 4
Mountain View 4
Newark 4
Rome 4
Seoul 4
Shenyang 4
Sydney 4
Ancona 3
Ardabil 3
Bangkok 3
Bari 3
Bethesda 3
Chicago 3
Evanston 3
Florence 3
Hangchou 3
Nanchang 3
Ridgefield 3
San Mateo 3
Settimo Torinese 3
Shaoxing 3
Tianjin 3
Verona 3
Zhengzhou 3
İzmit 3
Aarhus 2
Abuja 2
Atlanta 2
Totale 3.920
Nome #
BCAM and LAMA5 Mediate the Recognition between Tumor Cells and the Endothelium in the Metastatic Spreading of KRAS Mutant Colorectal Cancer 309
Phage Display-Based Nanotechnology Applications in Cancer Immunotherapy 296
Neuroblastoma-targeted nanocarriers improve drug delivery and penetration, delay tumor growth and abrogate metastatic diffusion 224
A peptide from the extracellular region of the synaptic protein α Neurexin stimulates angiogenesis and the vascular specific tyrosine kinase Tie2 167
PRUNE2 is a human prostate cancer suppressor regulated by the intronic long noncoding RNA PCA3 167
The neuronal pentraxin-2 pathway is an unrecognized target in human neuroblastoma which also offers prognostic value in patients 159
The combination of sorafenib and everolimus shows antitumor activity in preclinical models of malignant pleural mesothelioma 146
Targeted molecular-genetic imaging and ligand-directed therapy in aggressive variant prostate cancer 136
Anti-cancer effect and gene modulation of ET-743 in human biliary tract carcinoma preclinical models. 135
Brain endothelial cell-targeted gene therapy of neurovascular disorders 134
Towards a transcriptome-based theranostic platform for unfavorable breast cancer phenotypes 131
Self-targeting of TNF-releasing cancer cells in preclinical models of primary and metastatic tumors 130
Abstract LB-366: Everolimus (EV) potentiates Sorafenib (SOR)activity in osteosarcoma (OS) preclinical models: a combination targeting the crosstalk between ERK1/2 and mTORC1/2 signaling pathways 118
A complex of α6 integrin and E-cadherin drives the liver metastasis of colorectal cancer cells by a physical and functional interaction with hepatic angiopoietin-like 6 115
Abstract 5620: Novel phage display-derived neuroblastoma-targeting peptides potentiate the effect of drug nanocarriers in preclinical settings 115
Synchronous down-modulation of miR-17 family members is an early causative event in the retinal angiogenic switch 110
An antivascular vaccine to boost self-immunity and strike the tumor 108
Abstract 1163: Microenvironment targets in KRAS-mutated metastatic colorectal cancer 106
Abstract 3625: Novel phage-display derived peptides for tumor- and vasculature-targeted therapies in neuroblastoma 104
A novel mechanism of HIV-1 entry into host cells and peptides inhibiting this mechanism 103
Biological aspects of tumour angiogenesis 100
Autoantibodies against the cell surface-Associated chaperone GRP78 stimulate tumor growth via tissue factor 99
Therapeutic targeting of membrane-associated GRP78 in leukemia and lymphoma: preclinical efficacy in vitro and formal toxicity study of BMTP-78 in rodents and primates 96
A new computational approach to analyze human protein complexes and predict novel protein interactions 95
Anti-GRP78 autoantibodies induce endothelial cell activation and accelerate the development of atherosclerotic lesions 94
Abstract 1778: Characterization and anti-tumor functionality of a neuroblastoma-specific peptide, either free or conjugated to nanocarriers 93
IL-12-dependent innate immunity arrests endothelial cells in G0-G1 phase by a p21(Cip1/Waf1)-mediated mechanism. 88
Identification of CD36 molecular features required for its in vitro angiostatic activity. 86
Cell surface-associated Tat modulates HIV-1 infection and spreading through a specific interaction with gp120 viral envelope protein. 84
c-fos-induced growth factor/vascular endothelial growth factor D induces angiogenesis in vivo and in vitro. 81
BMTP-11 is active in preclinical models of human osteosarcoma and a candidate targeted drug for clinical translation 79
Antitumor activity of Src inhibitor Saracatinib (AZD-0530) in preclinical models of biliary tract carcinomas. 78
Going viral? Linking the etiology of human prostate cancer to the PCA3 long noncoding RNA and oncogenic viruses 75
Vascular endothelial growth factor-C stimulates the migration and proliferation of Kaposi's sarcoma cells. 75
126 POSTER Novel phage display-derived peptides for tumor- and vascular- targeted therapies against neuroblastoma 74
Interaction between Tumor Cell Surface Receptor RAGE and Proteinase 3 Mediates Prostate Cancer Metastasis to Bone 73
Targeting the extracellular signature of metastatic colon cancers 72
Emerging Pharmacologic Targets in Cerebral Cavernous Malformation and Potential Strategies to Alter the Natural History of a Difficult Disease: A Review 72
Phage display technology for novel tumor- and vascular-targeted therapies against neuroblastoma 69
Inhibitors of alpha 6/ E cadherin complex 68
Combined targeting of perivascular anf endothelial tumor cells enhances anti-tumor efficacy of liposomal chemotherapy in neuroblastoma 64
Peptidi metastasi-specifici e loro applicazioni diagnostiche e terapeutiche 63
SERS active Ag nanoparticles in mesoporous silicon: detection of organic molecules and peptide-antibody assays 62
An extra-cellular protein signature of metastatic colon cancer 62
Interleukin-11 Receptor Is a Candidate Target for Ligand-Directed Therapy in Lung Cancer: Analysis of Clinical Samples and BMTP-11 Preclinical Activity 60
TARGETED NANOMEDICINES FOR APPLICATIONS IN PRECLINICAL CANCER MODELS 60
Ligand-targeted theranostic nanomedicines against cancer 58
Targeted dual-color silica nanoparticles provide univocal identification of micrometastases in preclinicalmodels of colorectal cancer. 58
Overexpression of the RON gene in human breast carcinoma 57
Angiopoietin-like 7, a novel pro-angiogenetic factor over-expressed in cancer 57
Intracellular targeting of annexin A2 inhibits tumor cell adhesion, migration, and in vivo grafting 57
Emerging lymphae for the fountain of life. 54
Novel phage display-derived neuroblastoma-targeting peptides potentiate the effect of drug nanocarriers in preclinical settings 53
The V1/V2 loop of HIV-1 gp120 is necessary for Tat binding and consequent modulation of virus entry. 52
Aminopeptidase A is a functional target in angiogenic blood vessels 49
The Combination of Sorafenib and Everolimus abrogates mTORC-1 and mTORC2 up-regulation in preclinical models of Osteosarcoma. 44
Bacteriophages as therapeutic and diagnostic vehicles in cancer 40
Nanoparticles as Physically- and Biochemically-Tuned Drug Formulations for Cancers Therapy 37
Combination of peptides-targeted liposomal chemotherapy against neuroblastoma 35
Luminescent silica nanoparticles for cancer diagnosis 33
Targeting the extracellular signature of metastatic colorectal cancers 31
Investigation into the Use of Encorafenib to Develop Potential PROTACs Directed against BRAFV600E Protein 30
A functional idiotype/anti-idiotype network is active in genetically gluten-intolerant individuals negative for both celiac disease–related intestinal damage and serum autoantibodies 30
Paclitaxel Restores Sensitivity to Chemotherapy in Preclinical Models of Multidrug-Resistant Intrahepatic Cholangiocarcinoma 26
Advanced Cellular Models for Preclinical Drug Testing: From 2D Cultures to Organ-on-a-Chip Technology 10
Totale 5.846
Categoria #
all - tutte 14.173
article - articoli 0
book - libri 0
conference - conferenze 2.229
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.402


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019282 0 0 0 0 0 0 0 0 0 0 219 63
2019/20201.029 42 46 45 114 53 105 88 117 147 110 88 74
2020/2021946 80 106 82 86 76 59 57 54 87 64 53 142
2021/2022749 42 49 37 48 14 29 31 51 27 72 218 131
2022/20231.077 98 105 30 90 91 249 82 90 128 29 51 34
2023/2024412 72 68 30 27 51 73 41 14 5 28 3 0
Totale 5.846